Vnitr Lek 1995, 41(12):822-826

[Density of adhesive proteins after oral administration of proteolytic enzymes in multiple myeloma].

A Sakalová, R Kunze, D Holománová, J Hapalová, B Chorváth, M Mistrík, J Sedlák
Klinika hematológie a transfuziológie FN a Subkatedra hematológie a transfuziológie IVZ, Bratislava.

The authors present information on the presence of adhesive proteins on membranes of myeloma and precursor cells isolated from bone marrow and blood from a group of 33 patients examined by fluorescent flow cytometry. They also compare the density of integrins (CD29, CD49e, CD41, CD51 and CD61) and adhesive proteins from the group of "homing" receptors (CD44) and IgG "superfamily" (LFA-1, LFA-3, ICAM-1, N-CAM) and their changes after a single oral dose of a mixture of proteolytic enzymes (Wobe Mugos, Wobenzym, MUCOS Pharma, FRG). The authors observed a significant drop of CD29, CD54 (ICAM-1), CD58 (LFA-3) after Wobe Mugos, CD49, CD51, CD58 after Wobenzyme. The insignificant decline of density of CD44 on cells, as well as of the soluble receptor of CD44 after oral administration of proteolytic enzymes in serum, incl. the mentioned changes of integrins and other adhesive proteins, indicate the importance of enzyme preparations in the supporting treatment of malignant processes.

Keywords: Adjuvants, Immunologic, administration & dosage, ; Administration, Oral; Cell Adhesion Molecules, metabolism, ; Drug Combinations; Humans; Hydrolases, administration & dosage, ; Integrins, metabolism, ; Multiple Myeloma, metabolism, ; Rutin, administration & dosage,

Published: December 1, 1995  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sakalová A, Kunze R, Holománová D, Hapalová J, Chorváth B, Mistrík M, Sedlák J. [Density of adhesive proteins after oral administration of proteolytic enzymes in multiple myeloma]. Vnitr Lek. 1995;41(12):822-826.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.